Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v2-FR | Version v1-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2025-05-07 | 2025-05-07 |
| Drug Identification Number | 02421437 | 02421437 |
| Brand name | DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 21 | DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 21 |
| Common or Proper name | Drospirenone and Ethinyl Estradiol | Drospirenone and Ethinyl Estradiol |
| Company Name | GLENMARK PHARMACEUTICALS CANADA INC. | GLENMARK PHARMACEUTICALS CANADA INC. |
| Ingredients | ETHINYL ESTRADIOL DROSPIRENONE | ETHINYL ESTRADIOL DROSPIRENONE |
| Strength(s) | 0.03MG 3MG | 0.03MG 3MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL | ORAL |
| Packaging sizes (GTIN) | (See additional packaging sizes) | (See additional packaging sizes) |
| Additional packaging sizes | 3x21 | 3x21 |
| ATC code | G03AA | G03AA |
| ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2025-04-14 | 2025-04-14 |
| Estimated end date | 2025-07-15 | 2025-07-15 |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |